Circadian rhythm disturbances and conversion to psychosis in ultra high-risk youth by Goncalves, Bruno et al.











D1 - Day before blood collection 350 980 10.1 235
D2 - - 11.2 236
D3 - Upper gastrointestinal endoscopy: grade 4 reflux esophagitis
D11 - - 9.4 503
D17 250 633 6.9 481
D36 200 238 - -
D43 200 192 - -
D67 - Upper gastrointestinal endoscopy: fully healed esophagus
D77 250 270 - -
D84 250 263 - -
tolerance since the start of treatment. Nefopam was also
introduced for the management of hemorrhoid pain as
needed, at 20 mg/d (po). After an additional 35 days of
treatment with clozapine at 350 mg/d, one night the
patient had hematemesis and diffuse abdominal pain. The
next morning, she experienced vomiting and complained
of epigastric pain. The patient was treated with domper-
idone (30 mg/d) and metoclopramide (20 mg/d, po, as
needed). Clinical examination revealed reflux esophagitis
(grade 4) associated with a hiatal hernia (4 cm). A blood
test showed plasma clozapine levels of 980 mg/l (labora-
tory alert level is plasma concentration4 1,000 mg/L).2 In
this context, pantoprazole was introduced at a dosage of
20 mg/d, whereas domperidone was stopped after
1 week. Clozapine was gradually reduced to 200 mg/d.
After 15 days, gastroesophageal symptoms had dimin-
ished and clozapine levels had fallen to 633 mg/L
(therapeutic reference range = 350-600 mg/L).2 About
2 months after esophagitis, a gastroscopic control was
performed, demonstrating complete esophageal healing.
Table 1 synthesizes the clozapine dose changes following
intoxication along with the plasma levels of clozapine.
Some disorders affecting the gastrointestinal tract,
including cases of esophagitis with hiatal hernias, have
been reported with the use of clozapine, but very few
have been published.3 These gastrointestinal distur-
bances appear in connection with hypomotility and
changes in digestive secretion induced by clozapine, as
a result of its antiserotoninergic and anticholinergic
properties.3 Anticholinergic medications are often impli-
cated in exacerbating gastroesophageal reflux disease by
decreasing lower esophageal sphincter pressure and
consequently causing or aggravating heartburn, but such
conditions were not identified in our patient before the
occurrence of esophagitis.
In our patient, the combined use of clozapine,
tropatepine, and aripiprazole (stopped a week before
the adverse effect but with a long half-life) may have
enhanced the effects of clozapine by contributing to
anticholinergic and antiserotoninergic effects respectively
(nefopam was only administered on 2 days: 4 and
24 days before esophagitis). However, the dramatic
increase in clozapine blood concentration seems suffi-
cient to account for the adverse effect. To the best of our
knowledge, this is the first case of clozapine-induced
severe esophagitis correlated to a measured-level of
plasma clozapine to be published in the literature.
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Our group has recently showed that individuals in at risk
mental states for psychosis and bipolar disorder (BD)
have a poorer quality of sleep, start their daily activity
later, and have a fragmented circadian rhythm compared
with age and gender-matched healthy controls.1,2 Another
study shows that adolescents at high risk of developing
psychosis are more prone to nocturnal awakening, which
reduces sleep efficiency.3 Nevertheless, the relationship
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between circadian abnormalities and risk of transition to
psychosis remains poorly explored in the literature.4 Here
we present baseline data obtained at clinical assessment
of sleep and circadian rhythm in three patients in at-risk
states for psychosis who converted to a first episode of
psychosis during follow-up.
The first case is a male patient with a strong preference
for sleeping and waking up late. Polysomnography (PSG)
and actigraphy showed extreme incompatibility between
chronotype and social routine resulting in sleep restric-
tion. The patient had a 93-minute sleep extension when
sleep time was not restricted by routine activities.
The second case was classified as indifferent chron-
otype with sleep restriction (he slept 68 additional minutes
during the PSG test compared to his normal routine).
Furthermore, there was an increase of 100 minutes in
total sleep time over the weekend compared to week
days. The greatest difference in the amount of sleep was
recorded on Saturdays. The data sets show chronic sleep
restriction and advanced sleep phase imposed by routine.
The third case was an evening chronotype with no rigid
routine, who was able to sleep and wake up late. Because he
had an irregular wake-up pattern, a comparison between
weekday and weekend sleep was not possible. During the
active phase, 140 minutes were quantified as sleep by
actigraphy, suggesting that the patient took a nap or rested at
home. This finding was confirmed by the activity index, which
shows 85.24% of uptime. These results indicate an active
phase with rest, which was confirmed by high scores on the
questionnaire on daytime sleepiness (Epworth; Table 1). The
periods of rest during the awake time might be responsible for
the long sleep onset latency (in both PSG and actigraphy). No
sleep restriction was observed (actigraphy vs. PSG; Table 1).
The results showed a pattern of circadian rhythm
disturbance in the three cases, indicating the need for a
personalized sleep hygiene program. Tests such as actigra-
phy and PSG are important to identify whether rhythm
Table 1 Description of baseline sleep-awake cycle in three cases of at-risk mental states who transitioned to psychosis
Variable First case Second case Third case
Age 13- 19 23
HO score* 27- 46 37
Epworth scorew 5 1 10
Wake-up time (actigraphy) 05:07:19- 07:48:37 10:48:02
Wake-up time (PSG) 06:31:00 06:45:00 06:25:00
Best time to wake up (HO) 12:00:00 12:00:00 08:00:00
Start time of rest (actigraphy) 01:51:00 01:29:00 3:42:00-
Start time of rest (PSG) 23:07:00 22:54:00 23:58:00
Activity index in awake time 91.35 98.63+ 85.24
Sleep minutes in awake time 65.5 25.1 140.06+
Rest duration 279.8- 374.57 400.21
Total sleep time (PSG) 372.5 442.5 335
Latency min (actigraphy) 4.6 7.95 29.05++
Latency min (PSG) 20 0.1 39
Rest duration on weekdays 413
Rest duration on weekends 513.8
Wake up time on weekdays (actigraphy) 06:52:52
Wake up time on weekends (actigraphy) 09:30:20
Wake up time on Saturday (actigraphy) 10:37:40
HO = Horne-O¨stberg; PSG = polysomnography.
*Scores may range from 16 (eveningness) to 86 (morningness).
wScores may range from 0 (low propensity to sleep) to 24 (high propensity to sleep.
+Highest value compared with the groups described in Castro et al.1; ++ second highest value; - lowest value.
disturbances are a result of the challenge between chron-
otype and routine, of sleep deprivation per se, and/or of
daytime sleepiness. Further studies with longer duration
records and other rhythms such as temperature of the wrist
and exposure to light can provide more insights into circadian
rhythm disturbances and their conversion to psychosis.
The synchronization of circadian rhythms can be increased
by regular routine and more exposure to light.5 Higher levels
of physical activity should increase sleep rhythm amplitude
and reduce sleep fragmentation. A sleep hygiene program
can change the start and end times of sleep and its duration.
Our results suggest that these changes to improve the
circadian rhythm and sleep might help reduce conversions.
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Anorexia nervosa
presenting as a subacute
sensory-motor axonal
polyneuropathy
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Anorexia nervosa is a psychiatric disorder characterized by
abnormally low body weight associated with fear of gaining
weight, body image disturbance, and restriction of caloric
intake. It is categorized as restrictive when accompanied by
a reduction in calorie consumption; or as purging when there
is intentional overuse of diuretics, laxatives, or self-induced
vomiting. Anorexia affects 0.3 to 0.9% of young women and
0.3% of young men.1
Despite the knowledge regarding the deleterious effects
of anorexia nervosa on several organ systems,2 neurolo-
gical complications are still under-recognized. Only a few
case reports so far have linked anorexia nervosa to brain
atrophy3 and peripheral neuropathy.4,5
Here we report the case of a young woman with
subacute symptoms of peripheral polyneuropathy. Clinical
and laboratory work-up identified vitamin deficiency
secondary to hitherto undiagnosed anorexia nervosa.
A 24-year-old woman reported burning pain in her feet
for three months. Two months after the onset of
dysesthesia, she gradually developed a paralysis of the
lower limbs. At this point, she had an orthopedic
consultation which ruled out osteoarticular disease. Due
to the worsening of motor and sensitive symptoms, she
looked for medical assistance at the emergency depart-
ment of the university hospital at Universidade Federal de
Minas Gerais, Belo Horizonte, Brazil. She denied any
previous disease and use of drugs.
Physical examination showed a very thin woman with
body mass index of 14.9 kg/m2. Neurological examination
revealed absence of the deep reflexes in the lower limbs
along with paraparetic gait and ataxia.
Laboratory workup did not reveal any abnormalities in
complete blood count, electrolyte levels, renal, hepatic,
and thyroid functions, and thiamine. Reduced levels of
folate (2.05 nmol/L; normal values: 4 5.9 nmol/L) and
vitamin B12 (190 pg/mL; 200-900 pg/mL) were detected.
Electromyography confirmed the presence of symmetric
sensory-motor axonal polyneuropathy. No change in
gastric mucosa was evidenced by upper digestive
endoscopy with biopsy.
Since the patient denied diarrhea or other symptoms
that could indicate a malabsorption syndrome, a compre-
hensive approach tried to characterize her dietary habits.
She claimed to be vegetarian, with occasional consump-
tion of eggs and milk derivatives. She was afraid of
gaining weight, and over the past three years persistently
felt overweight. Moreover, she had morning episodes of
vomiting after breakfast, and consumed progressively
less food. The diagnosis of anorexia nervosa, restrictive
subtype, was established.
Her vitamin deficiency was treated with intramuscular
cyanocobalamin and oral vitamin B complex plus folic
acid supplementation. Gabapentin (900 mg/day) was
used for neuropathic pain. On follow-up she evolved with
complete remission of sensory and motor symptoms, and
recovery of normal weight and change of dietary habits
under psychiatric and dietitian supervision.
The association between anorexia nervosa and periph-
eral neuropathy has rarely been reported.4,5 A unique
feature of the present case was the diagnosis of anorexia
nervosa only after clinical and laboratory investigation of
polyneuropathy. Until then, her neurological symptoms and
weight loss were attributed to an undefined clinical
condition. The precise diagnosis prevented unnecessary
investigation, making clinical improvement possible.
Long periods of restricted food intake along with
frequent vomiting may promote significant reduction of
vitamin B12 acquisition. These facts, associated with the
patient’s vegetarian diet contributed to the development of
this peculiar clinical presentation. Moreover, the absence
of abnormalities on upper digestive endoscopy followed
by histological analysis excluded the presence of local
diseases that could justify B12 hypovitaminosis (e.g.,
atrophic gastritis). Clinical recovery with cyanocobalamin
administration corroborates the causal assumption pro-
posed. It should be mentioned that treatment of a case
such as the one we described cannot be limited to vitamin
supplementation and/or relieving of dysesthesia. Prompt
weight restoration under dietary and psychiatric super-
vision is also essential. The severity of physical symp-
toms associated with anorexia nervosa possibly con-
tributed to the patient’s adherence to treatment and/or
subsequent clinical improvement. Interestingly enough, a
positive outcome regarding the eating disorder has also
been reported for a severe case of anorexia nervosa
presenting with peripheral neuropathy and Wernicke
encephalopathy.5
The present case report highlights an atypical and
severe form of anorexia nervosa. Early recognition and
treatment of this illness might have prevented unneces-
sary neurological complications. Eating disorders must be
considered in the differential diagnosis of vitamin defi-
ciency syndromes.
Letters to the Editors 179
Rev Bras Psiquiatr. 2016;38(2)
